← Leaderboards
David Sacks
Niaid Extramural Activities
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Leishmaniasis”
- Wilhelmus G. J. Hol · University Of Washington$31,003,173
- Phillip A. Scott · University Of Pennsylvania$23,688,775
- Stephen M Beverley · Washington University$22,938,258
- Mary Edythe Wilson · University Of Iowa$10,364,568
- Diane McMahon Pratt · Yale University$7,903,133
- William H Gerwick · Oregon State University$7,792,712
Research focus
LeishmaniasisParasitesVaccinesInfectionImmune ResponseCellsIndiaSand FliesBiteVisceral LeishmaniasisLeishmaniaDosePathogenesisTransmission ProcessCutaneousSiteLesionVectorVaccine DevelopmentLeishmania MajorGeneticGenesResponseMacrophage
Grant awards (55)
Vector Biological Studies in Leishmaniasis$1,099,773
ZIA · FY2025 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$733,183
ZIA · FY2025 · AI · contact PI
Vector Biological Studies in Leishmaniasis$1,086,843
ZIA · FY2024 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$724,563
ZIA · FY2024 · AI · contact PI
Vector Biological Studies in Leishmaniasis$952,315
ZIA · FY2023 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$718,413
ZIA · FY2023 · AI · contact PI
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania$114,312
ZIA · FY2023 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$775,112
ZIA · FY2022 · AI · contact PI
Vector Biological Studies in Leishmaniasis$775,112
ZIA · FY2022 · AI · contact PI
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania$57,995
ZIA · FY2022 · AI · contact PI
Vector Biological Studies in Leishmaniasis$766,082
ZIA · FY2021 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$626,795
ZIA · FY2021 · AI · contact PI
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania$18,682
ZIA · FY2021 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$726,511
ZIA · FY2020 · AI · contact PI
Vector Biological Studies in Leishmaniasis$726,511
ZIA · FY2020 · AI · contact PI
Novel SARS-CoV-2 vaccine candidates: Live, recombinant Leishmania$22,137
ZIA · FY2020 · AI · contact PI
Vector Biological Studies in Leishmaniasis$911,807
ZIA · FY2019 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$607,872
ZIA · FY2019 · AI · contact PI
Vector Biological Studies in Leishmaniasis$857,801
ZIA · FY2018 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$571,867
ZIA · FY2018 · AI · contact PI
Vector Biological Studies in Leishmaniasis$794,014
ZIA · FY2017 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$529,343
ZIA · FY2017 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$692,603
ZIA · FY2016 · AI · contact PI
Vector Biological Studies in Leishmaniasis$461,735
ZIA · FY2016 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$780,595
ZIA · FY2015 · AI · contact PI
Vector Biological Studies in Leishmaniasis$520,397
ZIA · FY2015 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$701,552
ZIA · FY2014 · AI · contact PI
Vector Biological Studies in Leishmaniasis$467,702
ZIA · FY2014 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$724,994
ZIA · FY2013 · AI · contact PI
Vector Biological Studies in Leishmaniasis$483,329
ZIA · FY2013 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$818,932
ZIA · FY2012 · AI · contact PI
Vector Biological Studies in Leishmaniasis$545,955
ZIA · FY2012 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$725,877
ZIA · FY2011 · AI · contact PI
Vector Biological Studies in Leishmaniasis$663,831
ZIA · FY2011 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$722,890
ZIA · FY2010 · AI · contact PI
Vector Biological Studies in Leishmaniasis$722,890
ZIA · FY2010 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$625,700
ZIA · FY2009 · AI · contact PI
Vector Biological Studies in Leishmaniasis$625,700
ZIA · FY2009 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$655,874
Z01 · FY2008 · AI · contact PI
Vector Biological Studies in Leishmaniasis$655,874
Z01 · FY2008 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIASIS$850,811
Z01 · FY2007 · AI · contact PI
Vector Biological Studies in Leishmaniasis$850,811
Z01 · FY2007 · AI · contact PI
Vector Biological Studies in Leishmaniasis$0
Z01 · FY2006 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIAS$0
Z01 · FY2006 · AI · contact PI
IMMUNE REGULATION AND VACCINE DEVELOPMENT IN LEISHMANIAS$0
Z01 · FY2005 · AI
Analysis Of T Cell Responses In Leishmaniasis$0
Z01 · FY2004 · AI
Vector Biological Studies in Leishmaniasis$0
Z01 · FY2004 · AI
Analysis Of T Cell Responses In Leishmaniasis$0
Z01 · FY2003 · AI
Vector Biological Studies in Leishmaniasis$0
Z01 · FY2003 · AI
Analysis Of T Cell Responses In Leishmaniasis$0
Z01 · FY2002 · AI
Developmental Biology Of Leishmania Promastigotes$0
Z01 · FY2002 · AI
Analysis Of T Cell Responses In Human Leishmaniasis$0
Z01 · FY2001 · AI
Developmental Biology Of Leishmania Promastigotes$0
Z01 · FY2001 · AI
ANALYSIS OF T CELL RESPONSES IN HUMAN LEISHMANIASIS$0
Z01 · FY2000 · AI
DEVELOPMENTAL BIOLOGY OF LEISHMANIA PROMASTIGOTES$0
Z01 · FY2000 · AI